Intralesional Injections of a TNF-α Inhibitor to Treat Orofacial Granulomatosis
Inflammatory Bowel Diseases · 2024
DOI: 10.1093/ibd/izae001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Jasmine Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, NYU Langone Hospital - Long Island, Mineola, NY, USA. Hauptthemen laut MEDLINE: Granulomatosis, Orofacial. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Lay Summary We present the first documented case of successful treatment of orofacial granulomatosis by intralesional injections of a tumor necrosis factor α inhibitor to the lip. Our patient had rapid symptomatic improvement after 3 injections, and near resolution within 4 months of anti-tumor necrosis factor α therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, NYU Langone Hospital - Long Island, Mineola, NY, USA.
ORCID-Profile: Jasmine Lee
Zitieren
APA
Lee, J., Kurien, L., & Marciano, T. (2024). Intralesional Injections of a TNF-α Inhibitor to Treat Orofacial Granulomatosis. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae001
Vancouver
Lee J, Kurien L, Marciano T. Intralesional Injections of a TNF-α Inhibitor to Treat Orofacial Granulomatosis. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izae001
BibTeX
@article{Lee2024,
author = {Lee, Jasmine and Kurien, Lisa and Marciano, Tuvia},
title = {Intralesional Injections of a TNF-α Inhibitor to Treat Orofacial Granulomatosis},
journal = {Inflammatory Bowel Diseases},
year = {2024},
doi = {10.1093/ibd/izae001}
}
EUVIMED